- Home
- JNVR vs INCR Comparison
JNVR vs INCR Comparison
Compare JNVR & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JNVR
- INCR
- Stock Information
- Founded
- JNVR 2018
- INCR 1994
- Country
- JNVR United States
- INCR Israel
- Employees
- JNVR N/A
- INCR N/A
- Industry
- JNVR Finance: Consumer Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- JNVR Finance
- INCR Health Care
- Exchange
- JNVR Nasdaq
- INCR Nasdaq
- Market Cap
- JNVR 93.3M
- INCR 76.7M
- IPO Year
- JNVR 2023
- INCR N/A
- Fundamental
- Price
- JNVR $63.99
- INCR $1.58
- Analyst Decision
- JNVR
- INCR
- Analyst Count
- JNVR 0
- INCR 0
- Target Price
- JNVR N/A
- INCR N/A
- AVG Volume (30 Days)
- JNVR 1.9M
- INCR 15.0K
- Earning Date
- JNVR 05-13-2025
- INCR 05-01-2025
- Dividend Yield
- JNVR N/A
- INCR N/A
- EPS Growth
- JNVR N/A
- INCR N/A
- EPS
- JNVR N/A
- INCR N/A
- Revenue
- JNVR $2,099,660.00
- INCR $65,575,323.00
- Revenue This Year
- JNVR N/A
- INCR $69.54
- Revenue Next Year
- JNVR N/A
- INCR $41.75
- P/E Ratio
- JNVR N/A
- INCR N/A
- Revenue Growth
- JNVR 4.82
- INCR N/A
- 52 Week Low
- JNVR $3.37
- INCR $1.17
- 52 Week High
- JNVR $91.38
- INCR $3.39
- Technical
- Relative Strength Index (RSI)
- JNVR 57.60
- INCR 60.75
- Support Level
- JNVR $64.09
- INCR $1.55
- Resistance Level
- JNVR $91.38
- INCR $1.31
- Average True Range (ATR)
- JNVR 14.99
- INCR 0.08
- MACD
- JNVR -0.59
- INCR 0.02
- Stochastic Oscillator
- JNVR 53.59
- INCR 81.25
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from platform fees and subscription revenue.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.